SCHEMBL21796350

SCHEMBL21796350

CC(Nc1nccnc1-c1ccc(NC(=O)Cc2ccc(C(F)(F)C(C)O)cc2)c(F)c1)c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 3/20 0.40
▸ TNF P01375 2/20 0.35
▸ SCN1A P35498 1/20 0.35
▸ SCN5A Q14524 1/20 0.35
▸ SCN8A Q9UQD0 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ CA5A P35218 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ CA5B Q9Y2D0 1/20 0.34
▸ BDKRB1 P46663 2/20 0.34
▸ GSK3B P49841 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ RET P07949 1/20 0.33
▸ NTRK1 P04629 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19205749 1.00 RIPK1 (0.40) RIPK1TNFSCN1ASCN5ASCN8A
SCHEMBL21796351 0.88 TRPV1 (0.40) RIPK1MEN1KMT2ARETRORC
SCHEMBL19205763 0.88 TRPV1 (0.40) RIPK1MEN1KMT2ARETRORC
SCHEMBL22261805 0.85 RORC (0.42) RIPK1NTRK1RORCTP53
SCHEMBL19205583 0.85 RORC (0.42) RIPK1NTRK1RORCTP53
SCHEMBL19205594 0.79 KCNJ5 (0.42) MEN1KMT2ARETNTRK1RORC
SCHEMBL19205595 0.79 KCNJ5 (0.42) MEN1KMT2ARETNTRK1RORC
SCHEMBL21796353 0.75 NPC1 (0.42) MEN1KMT2ACA1CA2CA12
SCHEMBL19205657 0.75 NPC1 (0.42) MEN1KMT2ACA1CA2CA12
SCHEMBL21796354 0.75 SMN1; SMN2 (0.40) MEN1KMT2ARETRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331863-B1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2020-03-11 — — EP claimed
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback